Patent · US Active

Ganglioside based vaccine compositions for subcutaneous administration

US8591917B2 · kind B2 · utility

1Cited by

1References

15Claims

0Family size

Assignee

Centro de Inmunología Molecular · CU

Inventors

Luis Molina · Durham, US
Circe Mesa Pardillo · Boyeros, CU

Key dates

Filing date	Feb 27, 2004
Grant date	Nov 26, 2013
Priority date	—
Expiry date	Jan 28, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55555
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Vaccine compositions in which gangliosides and the OMP of N. meningitidis were combined to form very small size proteoliposomes (VSSP) to be administered subcutaneously are described, these compositions do not require the use of any additional adjuvant.The described compositions allow the immunological treatments with gangliosides, particularly N-AcGM3/VSSP and N-GcGM3/VSSP, showing advantages due to the less aggressive reaction in the site of injection and can be used in a simpler way and better for the patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.